Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer
Lawrence Fong, Andrew Hotson, John D. Powderly, et al.
Cancer Discovery (2019) Vol. 10, Iss. 1, pp. 40-53
Open Access | Times Cited: 274

Showing 1-25 of 274 citing articles:

Combination strategies with PD-1/PD-L1 blockade: current advances and future directions
Ming Yi, Xiaoli Zheng, Mengke Niu, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 879
The adenosine pathway in immuno-oncology
Bertrand Allard, David Allard, Laurence Buisseret, et al.
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 10, pp. 611-629
Closed Access | Times Cited: 405
Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors
Qingyang Lei, Dan Wang, Kai Sun, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 338
Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy
Chirag Krishna, Renzo G. DiNatale, Fengshen Kuo, et al.
Cancer Cell (2021) Vol. 39, Iss. 5, pp. 662-677.e6
Open Access | Times Cited: 282
Immunotherapy: Reshape the Tumor Immune Microenvironment
Bingzhe LV, Yunpeng Wang, Dongjiang Ma, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 281
Metabolic programming and immune suppression in the tumor microenvironment
Emily N. Arner, Jeffrey C. Rathmell
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 421-433
Open Access | Times Cited: 269
Beyond conventional immune-checkpoint inhibition — novel immunotherapies for renal cell carcinoma
David A. Braun, Ziad Bakouny, Laure Hirsch, et al.
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 4, pp. 199-214
Open Access | Times Cited: 258
Targeting CD39 in cancer
Achim K. Moesta, Xian-Yang Li, Mark J. Smyth
Nature reviews. Immunology (2020) Vol. 20, Iss. 12, pp. 739-755
Closed Access | Times Cited: 254
ATP and cancer immunosurveillance
Oliver Kepp, Lucillia Bezu, Takahiro Yamazaki, et al.
The EMBO Journal (2021) Vol. 40, Iss. 13
Open Access | Times Cited: 160
Cancer Cells Don’t Live Alone: Metabolic Communication within Tumor Microenvironments
Fuming Li, M. Celeste Simon
Developmental Cell (2020) Vol. 54, Iss. 2, pp. 183-195
Open Access | Times Cited: 156
Targeting the gut microbiota for cancer therapy
Miriam R. Fernandes, Poonam Aggarwal, Raquel Costa, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 12, pp. 703-722
Closed Access | Times Cited: 156
CD39/CD73/A2AR pathway and cancer immunotherapy
Chenglai Xia, Shuanghong Yin, Kenneth K.W. To, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 154
Cancer‐associated fibroblasts: Key players in shaping the tumor immune microenvironment
Mélanie Desbois, Yulei Wang
Immunological Reviews (2021) Vol. 302, Iss. 1, pp. 241-258
Closed Access | Times Cited: 138
Second Near‐Infrared Light‐Activatable Polymeric Nanoantagonist for Photothermal Immunometabolic Cancer Therapy
Cheng Xu, Yuyan Jiang, Jingsheng Huang, et al.
Advanced Materials (2021) Vol. 33, Iss. 36
Closed Access | Times Cited: 136
New Insights Into the Cancer–Microbiome–Immune Axis: Decrypting a Decade of Discoveries
Tejeshwar Jain, Prateek Sharma, Abhi C. Are, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 132
Targeting nucleotide metabolism: a promising approach to enhance cancer immunotherapy
Huailiang Wu, Yue Gong, Peng Ji, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 112
Adenosine-A2A Receptor Pathway in Cancer Immunotherapy
Changfa Sun, Bochu Wang, Shilei Hao
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 98
Immunosuppression in tumor immune microenvironment and its optimization from CAR-T cell therapy
Zaoqu Liu, Zhaokai Zhou, Qin Dang, et al.
Theranostics (2022) Vol. 12, Iss. 14, pp. 6273-6290
Open Access | Times Cited: 93
Next steps for clinical translation of adenosine pathway inhibition in cancer immunotherapy
Ryan C. Augustin, Robert D. Leone, Aung Naing, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 2, pp. e004089-e004089
Open Access | Times Cited: 82
Targets of Immune Escape Mechanisms in Cancer: Basis for Development and Evolution of Cancer Immune Checkpoint Inhibitors
Shovan Dutta, Anirban Ganguly, Kaushiki Chatterjee, et al.
Biology (2023) Vol. 12, Iss. 2, pp. 218-218
Open Access | Times Cited: 76
Targeting Cbl-b in cancer immunotherapy
Ryan C. Augustin, Riyue Bao, Jason J. Luke
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 2, pp. e006007-e006007
Open Access | Times Cited: 50
Beyond CTLA-4 and PD-1 Inhibition: Novel Immune Checkpoint Molecules for Melanoma Treatment
Dimitrios C. Ziogas, Charalampos Theocharopoulos, Panagiotis-Petros Lialios, et al.
Cancers (2023) Vol. 15, Iss. 10, pp. 2718-2718
Open Access | Times Cited: 48
Treatment strategies for clear cell renal cell carcinoma: Past, present and future
Junwei Yang, Kuansong Wang, Zhichun Yang
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 46
Targeting CD73 to augment cancer immunotherapy
Meejeon Roh, Derek A. Wainwright, Jennifer D. Wu, et al.
Current Opinion in Pharmacology (2020) Vol. 53, pp. 66-76
Open Access | Times Cited: 120
Conversion of extracellular ATP into adenosine: a master switch in renal health and disease
Karen M. Dwyer, Bellamkonda Kishore, Simon C. Robson
Nature Reviews Nephrology (2020) Vol. 16, Iss. 9, pp. 509-524
Closed Access | Times Cited: 103
Page 1 - Next Page

Scroll to top